Screening and Referral Workflow
BehavioralThe Screening and Referral Workflow intervention will include screening eligible patients for employment-related needs and referring those who require support to community-based employment resources.
NCT Number: NCT07027449
The goal of this clinical trial is to learn if a clinical workflow that screens adult patients with cancer for challenges at work and refers them to supportive resources is feasible, appropriate, and acceptable to patients and staff members in 2 cancer care settings. The main questions it aims to answer are:
Is the clinical workflow feasible and acceptable to participants? Are study procedures feasible and acceptable to participants?
Patient participants will complete 2 surveys: 1 at the time of enrollment and 1 six months later.
Trial opening soon.
Get NotifiedInvestigators will conduct a prospective single-arm study at 2 sites to pilot and iteratively adapt a clinical workflow intervention, implementation strategies, and associated study procedures. Investigators will implement the clinical workflow intervention across each study site, then recruit consecutive patients (n=50) to complete patient-reported measures at 2 time points (T1: enrollment; T2: 6-month follow-up. Investigators will recruit staff members (n=20) to complete survey measures at 2 time points (T1: beginning of pilot study period; T2: end of pilot study period).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Eligible Patients:
Eligible Staff:
The Screening and Referral Workflow intervention will include screening eligible patients for employment-related needs and referring those who require support to community-based employment resources.
Time frame: Baseline
T1 survey enrollment rate among eligible patients and staff
Time frame: 6 months
Rate of study survey completion within 18 days of the 6-month follow-up timepoint
Time frame: Approximately 9 months
Proportion of staff disagreeing with one or more Feasibility of Intervention Measure items
Time frame: Approximately 9 months
Proportion of staff disagreeing with one or more Acceptability of Intervention Measure items
Time frame: Baseline; 6 months
Proportion of patients providing negative ratings for one or more Theoretical Framework of Acceptability questionnaire items
Time frame: Baseline
Proportion of eligible patients screened for employment concerns
Time frame: Baseline; 6 months
Patient-reported employment status using the US Census Bureau's American Community Survey employment status items
Time frame: Baseline; 6 months
Patient-reported sick leave duration reported in days
Time frame: Baseline; 6 months
Patient-reported quality of life using the EQ-5D-5L scale. Scores range 1-5, with higher scores indicating poorer quality of life (worse outcome).
Time frame: Baseline; 6 months
Patient-reported health insurance status using the US Census Bureau's American Community Survey health insurance status items
Time frame: Baseline; 6 months
Patient-reported self-efficacy using the General Self-Efficacy Scale. Scores range 10-40, with higher scores indicating more self-efficacy (better outcome).
Time frame: Baseline; 6 months
Patient-reported financial toxicity using the COST measure. Scores range 0-48, with higher scores indicating more financial toxicity (worse outcome).
Contact information is provided by the study sponsor or research team.
University of Kansas Medical Center
Other
Implementing Pathways to Identify and Address Employment Concerns Among People With Cancer Across Diverse Clinical Settings
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739563
Behavior, Breast Cancer
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07739849
Cancer, Hemic and Lymphatic Diseases
View Trial DetailsNCT07735442
Cancer, Neoplasms
Boston, Massachusetts, United States
View Trial DetailsNCT07731425
Cancer, Neoplasms
Boston, Massachusetts, United States
View Trial Details